Ann: Dr Arthur Martin joins Scientific Advisory Board, page-28

The Nasal Balm product will be the real game changer for this Company revenue wise imo….

What is the efficacy or potential of Nasal Balm Sanitiser for Holista from your point of view?

"The nose is very sensitive. As such, you cannot easily use substances in there and have it line the inner nose for a long time. Compared to most other medical or healthcare substances, Path-Away® is benign to the nasal membranes. As it is odourless, it is exceptionally suited for the human nose.
Our new product will be a pharmaceutically enhanced balm for specific nasal use. We expect it to extend Path-Away®’s effectiveness for 8 to 12 hours (compared to 1–2 hours for a spray from the sanitiser). This will make it a very useful part of daily living.
We are now working on the prototypes and expect to file patents by end March 2020. The product will be ready for sale by June 2020. We expect regulatory clearance as “personal care” or “cosmetic”. This means quick and easy regulatory approvals in most countries and fast access to the market. "